New Developments in Vaginal Rings for Contraception

Over the last few decades, new contraceptives with lower concentrations of hormones administered through different routes have been developed. The vaginal contraceptive ring is a relatively new, effective, safe, self-administered hormonal contraceptive method that is increasingly being tested and us...

Full description

Saved in:
Bibliographic Details
Published inCurrent obstetrics and gynecology reports Vol. 3; no. 2; pp. 143 - 149
Main Authors Guazzelli, Cristina Aparecida Falbo, Barbieri, Marcia, Vieira, Carolina Sales, Torloni, Maria Regina
Format Journal Article
LanguageEnglish
Published Boston Springer US 01.06.2014
Subjects
Family Planning (A Burke
Maternal and Child Health
Medicine
Medicine & Public Health
Obstetrics/Perinatology/Midwifery
Oncology
Section Editor
Vaginal ring
Family planning
Contraceptive vaginal ring
Combined hormonal contraception
Contraception
Vaginal contraception
Non-oral contraception
Online AccessGet full text

Cover

More Information
Summary:Over the last few decades, new contraceptives with lower concentrations of hormones administered through different routes have been developed. The vaginal contraceptive ring is a relatively new, effective, safe, self-administered hormonal contraceptive method that is increasingly being tested and used. Vaginal rings that release new progestins and estrogens are being developed to reduce side effects and risks, and offer new choices to users. Currently, there are only two commercially available contraceptive rings: a monthly ring containing etonogestrel and ethinylestradiol (NuvaRing®) and a progesterone-only ring for lactating women that can be used for three months (Progering®). To increase the use of this method, recent and ongoing studies are testing rings with progesterone receptor modulators, estradiol and antiretroviral drugs for their indications and safety.
ISSN:2161-3303
2161-3303
DOI:10.1007/s13669-014-0080-0